Zebra Technologies Corp. announced the results of its Future of Healthcare: 2022 Hospital Vision Study, revealing the impact of mobile technology use in acute care hospitals. The research — which incorporates feedback from nursing managers, information technology (IT) decision-makers and patients — offers a perspective from the front-line of patient care. It also highlights the transformational power clinical mobility is expected to have on global health services within the next five years.
The rapid pace of change continues to be a hallmark in cardiovascular medicine and many see that pace accelerating. In ...
January 31, 2018 — Overall survival has improved for the about 200,000 patients experiencing in-hospital cardiac arrest ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 30, 2018 — Amazon , Berkshire Hathaway and JPMorgan Chase & Co. announced that they are partnering on ways to ...
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee in 2017 to push healthcare reform forward, spotlighting the committee’s role in protecting reimbursement rates for interventional cardiology procedures.
January 29, 2018 — The American Society of Echocardiography (ASE) announced that ImageGuideEcho, a module under the ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Take a video tour of some of the medical devices designed to improve patient care, improve patient engagement and ...
January 26, 2017 — Results from a core lab analysis from the PROMISE Trial on cardiac computed tomography (CT) were ...
January 26, 2018 — LivaNova PLC and MicroPort Scientific Corp. announced the companies have entered into a binding ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Medtronic plc announced the initiation of its investigational device exemption (IDE) study for the Abre venous self-expanding stent system. The ABRE IDE Study will evaluate the safety and effectiveness of the Abre stent in subjects with iliofemoral venous outflow obstruction. The first procedure was performed in December of 2017, by Erin Murphy, M.D., director of the venous and lymphatic program at Carolinas HealthCare System’s Sanger Heart & Vascular Institute in Charlotte, N.C., and national principal investigator for the ABRE IDE Study in the United States.
January 25, 2018 – Modalixx G202MDL is a new grayscale High Bright medical LCD solution for modality CRT monitor ...
January 25, 2018 – Canon Medical Systems, in partnership with Quality Electrodynamics (QED), installed a Vantage Galan ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
January 25, 2018 – Penumbra Inc. today announced results of the company-sponsored PROMISE Study, demonstrating real ...
January 25, 2018 – Advances in brain imaging can identify a greater number of stroke patients who can receive therapy ...
January 25, 2018 – According to the latest market study released by Technavio, the global circulatory support devices ...